Extended Data Fig. 3: Plot of the baseline to day 360 changes in MELD score (∆MELD).
From: Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial
Individual line plots are shown for each participant. Treatment allocation is separated into participants that received three cell infusions, single cell infusions and control (standard of care).
